Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
Clinical trial NCT03927222 · TERMINATED
Trial details
- NCT number
- NCT03927222
- Sponsor
- Mustafa Khasraw, MBChB, MD, FRCP, FRACP
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2023-02-10
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.